Wei Binxian
SEC CIK 1773586 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PALI | PALISADE BIO, INC. | Dir | 593.2K | — | — | 4 | 2024-06-11 | 2026-06-10 |
Most active insiders at PALI, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Finley John David | CEO, CFO, Dir | — | $310.2K |
| 2 | Baltera Robert Jr. | Dir | $250.2K | — |
| 3 | Jones Mitchell Lawrence | Chief Medical Off | — | $110.0K |
| 4 | Williams Donald Allen | Dir | $17.8K | — |
| 5 | Zwick Jordan Michael | Dir | — | — |
| 6 | Chuang Emil | Dir | — | — |
| 7 | Wei Binxian | Dir | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-12 20:14 | 2026-06-10 | PALI | PALISADE BIO, INC. | Wei Binxian | Dir | A - Grant | — | +592.3K | 593.2K | +69,275% | — |
| D | 2026-06-12 20:14 | 2026-06-10 | PALI | PALISADE BIO, INC. | Wei Binxian | Dir | M - OptEx | — | +20.2K | 613.4K | +3% | — |
| 2024-11-22 | 2024-11-21 | PALI | PALISADE BIO, INC. | Wei Binxian | Dir | M - OptEx | $0.00 | +388 | 855 | +83% | $0 | |
| 2024-06-12 | 2024-06-11 | PALI | PALISADE BIO, INC. | Wei Binxian | Dir | M - OptEx | $0.00 | +465 | 467 | +23,250% | $0 |
Purchase Sale Sale after option exercise All abbreviations